Skip to main content
SpringerLink
Log in

The Occurrence of Factor VIII Inhibitor in a Patient with Mild Hemophilia A - During Treatment with Interferon for Chronic Hepatitis C

  • Conference paper
36th Hemophilia Symposium Hamburg 2005

  • 464 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Herman C, Boggio L, Green D. Factor VIII inhibitor associated with interferon. Haemophilia 2005;11:408–10.

    Article  PubMed  CAS  Google Scholar 

  2. Regina S, Colombat P, Fimbel B, et al. Acquired inhibitor to factor VIII in a patient with Hodgkin’s disease following treatment with interferon-alpha. Haemophilia 2001;:7:526–7.

    Article  PubMed  CAS  Google Scholar 

  3. Stricker RB, Barlogie B, Kiprov DD.Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy. J Rheumatol 1994;21:350–2

    PubMed  CAS  Google Scholar 

  4. Ehrenforth S, Kreuz W, Scharrer I, et al. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992;339:594–8.

    Article  PubMed  CAS  Google Scholar 

  5. von Auer C, Oldenburg J, von Depka M, et al. Inhibitor development in patients with hemophilia A after continuous infusion of factor VIII concentrates. Ann N Y Acad Sci 2005;1051:498–505.

    Article  Google Scholar 

  6. Bril WS, MacLean PE, Kaijen PH, et al. HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation. Haemophilia 2004;10(5):509–14.

    Article  PubMed  CAS  Google Scholar 

  7. d’Oiron R, Volot F, Reynaud J, et al. Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia a and inhibitors. Semin Hematol 2006;43(1):S3–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. W. Miesbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Llugaliu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Asmelash
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ch. von Auer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Scharrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. III. Med. Clinic, University Hospital, Langenbeckstr. 1, D-55131, Mainz, Germany

    Inge Scharrer

  2. Dept. of Hemostaseology, University Hospital, Ziemssenstr. 1a, D-80336, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Verlag Berlin Heidelberg

About this paper

Cite this paper

Miesbach, W., Llugaliu, B., Asmelash, G., von Auer, C., Scharrer, I. (2007). The Occurrence of Factor VIII Inhibitor in a Patient with Mild Hemophilia A - During Treatment with Interferon for Chronic Hepatitis C. In: Scharrer, I., Schramm, W. (eds) 36th Hemophilia Symposium Hamburg 2005. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-36715-4_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-36715-4_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-36714-7

  • Online ISBN: 978-3-540-36715-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation